ArticleCureus2025
Comparison of the Efficacy of Ultrasound-Guided Suprascapular Nerve Block Versus Intra-articular Platelet-Rich Plasma in Periarthritis Shoulder Pain: A Randomized Controlled Trial.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe study aimed to compare the effect of ultrasound-guided suprascapular nerve block (SSNB) to intra-articular platelet-rich plasma (PRP) in the management of periarthritis shoulder (PA shoulder).
methodsThis study was a single-center randomized, interventional clinical trial conducted in the Department of Physical Medicine and Rehabilitation of Uttar Pradesh University of Medical Sciences (UPUMS), a tertiary care teaching hospital in Saifai, Etawah, over a period of 12 months from April 2024 to April 2025. Sixty patients were randomly divided into two groups (30 each). Group A received 3 ml of PRP under ultrasound guidance, and Group B underwent ultrasound-guided SSNB using 10 ml of 0.5% bupivacaine. Outcomes were assessed at the baseline and at the second, sixth, and 12th weeks post-intervention using the Shoulder Pain and Disability Index (SPADI) scale, Visual Analogue Scale (VAS), and range of motion (ROM).
resultsBoth groups showed significant improvement across all measures over time. However, on intergroup comparison, the total SPADI score was insignificant at two weeks, but it became significant at six and 12 weeks in favour of the PRP group. The VAS score also favoured the PRP group throughout the study period. In the ROM, flexion and abduction were significantly improved in the PRP group, while external rotation showed no significant difference at the second week but became significant at six and 12 weeks.
conclusionsBoth USG-guided IA-PRP and SSNB are effective in PA shoulder pain management, but IA-PRP yields superior outcomes in the short to medium term.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.